CD154 Blockade and Donor-Specific Transfusions in DLA-Identical Marrow Transplantation in Dogs Conditioned with 1-Gy Total Body Irradiation

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 2, 2007, Pages 164-171

  Jochum, Christoph ^a   Beste, Mechthild ^a   Zellmer, Eustacia ^a   Graves, Scott S ^a   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Anti CD154 antibody; Costimulatory blockade; Dogs; Marrow transplantation; Nonmyeloablative conditioning

Indexed keywords

CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN; DIPHENHYDRAMINE; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CROSS REACTION; DOG; DONOR; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; ENGRAFTMENT; GASTROINTESTINAL DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INHIBITION KINETICS; INTESTINE SURGERY; INTUSSUSCEPTION; LYMPHOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RADIATION DOSE; SINGLE DRUG DOSE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ANIMALS; ANTILYMPHOCYTE SERUM; BONE MARROW TRANSPLANTATION; CD40 LIGAND; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, RADIATION; GRAFT SURVIVAL; IMMUNOSUPPRESSION; LEUKOCYTE TRANSFUSION; SIBLINGS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 33846308903     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.10.031     Document Type: Article

References (25)

1. Storb R., Yu C., Wagner J.L., et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89 (1997) 3048-3054
2. Hogan W.J., Little M.-T., Zellmer E., et al. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant 9 (2003) 489-495
3. Storb R., Yu C., Zaucha J.M., et al. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100-cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94 (1999) 2523-2529
4. Seung E., Mordes J.P., Rossini A.A., et al. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. J Clin Invest 112 (2003) 795-808
5. Pan Y., Luo B., Sozen H., et al. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy. Transplantation 76 (2003) 216-224
6. Elster E.A., Hale D.A., Mannon R.B., et al. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials. Transplant Immunol 13 (2004) 87-99
7. Wagner J.L., Burnett R.C., DeRose S.A., et al. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 62 (1996) 876-877
8. Wagner J.L., Works J.D., and Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. Tissue Antigens 52 (1998) 397-401
9. + T cells that induces contact-dependent B-cell differentiation (help). J Exp Med 175 (1992) 1091-1101
10. Raff R.F., Deeg H.J., Farewell V.T., et al. The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. Tissue Antigens 21 (1983) 360-373
11. Koyama I., Kawai T., Andrews D., et al. Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation 77 (2004) 460-462
12. Buhler L., Alwayn I.P., Appel III J.Z., et al. Anti-CD154 monoclonal antibody and thromboembolism. Transplantation 71 (2001) 491
13. Diaconescu R., Little M.-T., Leisenring W., et al. What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?. Biol Blood Marrow Transplant 11 (2005) 335-344
14. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 58 (1994) 701-706
15. Elster E.A., Xu H., Tadaki D.K., et al. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 72 (2001) 1473-1478
16. Kirk A.D., Harlan D.M., Armstrong N.N., et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 94 (1997) 8789-8794
17. Gobburu J.V., Tenhoor C., Rogge M.C., et al. Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys. J Pharmacol Exp Ther 286 (1998) 925-930
18. Brams P., Black A., Padlan E.A., et al. A humanized anti-human CD154 monoclonal antibody blocks CD154-CD40-mediated human B-cell activation. Int Immunopharmacol 1 (2001) 277-294
19. Adams A.B., Pearson T.C., and Larsen C.P. Heterologous immunity: an overlooked barrier to tolerance. Immunol Rev 196 (2003) 147-160
20. Adams A.B., Williams M.A., Jones T.R., et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111 (2003) 1887-1895
21. Clarkson M.R., and Sayegh M.H. T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 80 (2005) 555-563
22. Wekerle T., Kurtz J., Ito H., et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 6 (2000) 464-469
23. Wekerle T., Sayegh M.H., Ito H., et al. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 68 (1999) 1348-1355
24. Jin Y.Z., and Xie S.S. Bicistronic adenovirus-mediated gene transfer of the CTLA4Ig and CD40Ig genes results in indefinite survival of islet xenograft. Transplant Proc 35 (2003) 3165-3166
25. Jochum C., Beste M., Zellmer E., et al. Donor-specific mononuclear cell transfusion and methotrexate as pretransplant treatment in dogs given DLA-identical marrow grafts after nonmyeloablative conditioning. [letter]. Biol Blood Marrow Transplant 12 (2006) 885-886